Glimda-MV 1 Tablet SR
Manufacturer
Cipla Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Key Information
Short Description
Glimda-MV 1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Dosage Form
Tablet SR
Introduction
Glimda-MV 1 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimda-MV 1 Tablet SR is to be taken empty stomach.
How it works
Glimda-MV 1 Tablet SR is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Tribetrol 1 Tablet
Glimy M V1 Tablet
Glucoryl-MV1 Tablet
Vogs-GM 1 Tablet
Vogli-GM 1 Tablet
Zoryl-MV 1 Tablet
Voglimac GM 1 Tablet SR
Trivoglitor 1 Tablet
Voglinorm-GM1 Tablet
Glimisave MV 1 Tablet
Frequently asked questions
What is Glimda-MV 1 Tablet SR?
Glimda-MV 1 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, helping to regulate blood glucose levels when taken with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, while Metformin lowers glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces postprandial glucose levels. This medication is not suitable for treating type 1 DM.
What are the possible side effects of Glimda-MV 1 Tablet SR?
Common side effects of Glimda-MV 1 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Are there any specific conditions in which Glimda-MV 1 Tablet SR should not be taken?
Glimda-MV 1 Tablet SR should be avoided in patients with known allergies to its components or excipients. It is also contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glimda-MV 1 Tablet SR?
No, it is not recommended to consume alcohol while taking Glimda-MV 1 Tablet SR, as it may increase the risk of hypoglycemia and lactic acidosis.
Can the use of Glimda-MV 1 Tablet SR cause hypoglycemia?
Yes, Glimda-MV 1 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regular blood sugar monitoring is essential. Always carry glucose tablets, honey, or fruit juice with you.
What are the instructions for the storage and disposal of Glimda-MV 1 Tablet SR?
Store Glimda-MV 1 Tablet SR in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of unused medication and ensure it is not consumed by pets, children, or other individuals.
